Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Icon Plc (ICLR)

Icon Plc (ICLR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,599,947
  • Shares Outstanding, K 53,622
  • Annual Sales, $ 2,806 M
  • Annual Income, $ 373,990 K
  • 60-Month Beta 0.83
  • Price/Sales 3.40
  • Price/Cash Flow 20.47
  • Price/Book 6.04

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 1.54
  • Number of Estimates 8
  • High Estimate 1.63
  • Low Estimate 1.47
  • Prior Year 1.74
  • Growth Rate Est. (year over year) -11.49%

Price Performance

See More
Period Period Low Period High Performance
1-Month
170.27 +7.56%
on 09/24/20
190.39 -3.81%
on 09/16/20
-2.18 (-1.18%)
since 08/25/20
3-Month
158.63 +15.45%
on 06/26/20
199.83 -8.35%
on 07/23/20
+20.47 (+12.58%)
since 06/25/20
52-Week
104.28 +75.63%
on 03/18/20
199.83 -8.35%
on 07/23/20
+31.25 (+20.57%)
since 09/25/19

Most Recent Stories

More News
ICON Launches Accellacare a Global Clinical Research Network Focused on Increasing Patient Recruitment With a Patient Centric Approach

ICON plc, (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device industries and government and public...

ICLR : 183.14 (+2.30%)
ICON plc to Present at Wells Fargo 2020 Virtual Global Healthcare Conference and Baird 2020 Global Healthcare Conference

ICON plc, (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations,...

WFC : 23.64 (+1.37%)
ICLR : 183.14 (+2.30%)
Pharmacovigilance Market Worth $12.25 Billion at 12.3% CAGR; Pharmaceutical Giants Such as Bayer and IQVIA to Focus on Launching Tracking Applications for PV Operations: Fortune Business Insights(TM)

Global pharmacovigilance market size is projected to reach USD 12.25 billion by 2027, exhibiting a CAGR of 12.3% during the forecast period. Initiation of awareness campaigns to disperse information among...

ICLR : 183.14 (+2.30%)
Forbes names ICON in list of Best Employers in America for Women

ICON plc, (NASDAQ: ICLR) a leading global provider of drug development and commercialisation services to the pharmaceutical, biotechnology and medical device industries today announced that it has been...

ICLR : 183.14 (+2.30%)
Amid the COVID-19 crisis and the looming economic recession, the Medical Device Outsourcing market worldwide will grow by a projected US$93.7 Billion, during the analysis period

, /PRNewswire/ -- Amid the COVID-19 crisis and the looming economic recession, the Medical Device Outsourcing market worldwide will grow by a projected , during the analysis period, driven by a revised...

BHE : 19.74 (+0.92%)
CLS : 6.79 (-2.86%)
ICLR : 183.14 (+2.30%)
ITGR : 58.72 (+2.95%)
MFAC : 10.30 (unch)
NSYS : 4.52 (-1.67%)
PLXS : 69.35 (-0.83%)
SPA : 18.51 (+0.11%)
WST : 269.51 (+2.23%)
The global bioanalytical testing services market is projected to reach USD 3.7 billion by 2025 from USD 2.1 billion in 2020, at a CAGR of 11.8%

, /PRNewswire/ --

ERRFY : 17.7000 (-14.86%)
ICLR : 183.14 (+2.30%)
LH : 180.99 (+1.77%)
PRXL : 88.08 (-0.02%)
PRAH : 97.29 (+1.28%)
SGSOF : 2,650.0000 (+1.21%)
ICON plc to Present at Jefferies Virtual Healthcare Conference

ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, today announced that Dr. Steve...

ICLR : 183.14 (+2.30%)
The Global Real World Evidence Solution Market is expected to grow from USD 765.13 Million in 2018 to USD 1,785.13 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 12.86%

, /PRNewswire/ --

ICLR : 183.14 (+2.30%)
IBM : 118.95 (+0.73%)
MHMNF : 54.5000 (unch)
ORCL : 59.80 (+0.84%)
Pharmacovigilance Market to Hit USD 12.25 Billion by 2027; Rising Consumption of Varied Medicines by Patients to Fuel Market Growth: Fortune Business Insights(TM)

The global pharmacovigilance market size is projected to reach USD 12.25 billion by 2027, exhibiting a CAGR of 12.3% during the forecast period. Initiation of awareness campaigns to disperse information...

ICLR : 183.14 (+2.30%)
The companion diagnostics industry analysis projects the market to grow at a significant CAGR of 12.45% during the forecast period, 2020-2030

, /PRNewswire/ -- Read the full report: • What are the long-term and short-term impacts of companion diagnostics on the human health continuum?• What are the major market drivers, challenges, and...

ABT : 103.45 (+2.51%)
A : 97.69 (+1.40%)
ICLR : 183.14 (+2.30%)
ILMN : 299.89 (+4.74%)
MYGN : 12.44 (+2.81%)
QGEN : 51.92 (+1.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade ICLR with:

Business Summary

ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.

See More

Key Turning Points

2nd Resistance Point 188.10
1st Resistance Point 185.62
Last Price 183.14
1st Support Level 179.22
2nd Support Level 175.30

See More

52-Week High 199.83
Last Price 183.14
Fibonacci 61.8% 163.33
Fibonacci 50% 152.05
Fibonacci 38.2% 140.78
52-Week Low 104.28

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar